Stem Cells: The Secret To Immortality FULL DOCUMENTARY | The Dock

00:45:57
https://www.youtube.com/watch?v=qI_VlZtLSR4

Ringkasan

TLDRThe video discusses the potential of stem cells in medicine, particularly their ability to differentiate into various cell types and support the repair of tissues. It highlights the types of stem cells, including embryonic and adult stem cells, as well as induced pluripotent stem cells (iPSCs). The video outlines stem cell functionalities, their sources, and the role of stem cells in regenerative medicine, presenting examples like bone marrow transplantation. Moreover, it examines the historical context of stem cell research, beginning with key discoveries in the 1960s, and emphasizes their important roles in tissue engineering and regenerative therapies. Ethical considerations related to embryonic stem cells are discussed, as well as the debate surrounding the use of human embryos. The video also touches on legislative aspects and regulatory challenges affecting stem cell research. It mentions the potential therapeutic applications of stem cells for treating diseases like diabetes, Alzheimer’s, and spinal cord injuries, acknowledging the challenges such as tissue rejection and tumor formation. Additionally, it signifies alternative sources for stem cells, such as those from amniotic fluid, which bypass some ethical issues.

Takeaways

  • 🧬 Stem cells can differentiate into various cell types, crucial for tissue repair.
  • 👶 Embryonic and adult stem cells are the primary types, each with unique properties.
  • 🌱 Induced pluripotent stem cells (iPSCs) offer a promising alternative to embryonic cells.
  • 🧠 Stem cell research is pivotal for advancing regenerative medicine.
  • ⚖️ Ethical debates center on the use of embryonic stem cells due to moral concerns.
  • 🩺 Stem cell therapies could revolutionize treatment for diseases like Parkinson's and diabetes.
  • 🧪 DNA repair mechanisms in stem cells are linked to aging and cell health.
  • 🔬 Alternatives like amniotic fluid-derived stem cells circumvent some ethical issues.
  • 💉 Challenges such as immune rejection and tumor risk remain in stem cell therapies.
  • 📜 Government regulations significantly impact the direction and funding of stem cell research.

Garis waktu

  • 00:00:00 - 00:05:00

    Stem cells hold potential as a key to immortality by contributing to the longevity of human life through scientific advances in medicine. These cells can differentiate into various cell types and self-renew, serving vital roles in both embryonic development and adult tissue repair. Found in embryonic and adult forms, they replenish tissues, and advancements have even allowed artificial growth and differentiation into specialized cells. The foundational research began with McCullock and Till's work in the 1960s, focusing on the self-renewal and potency—essential characteristics of stem cells. Their functionality relies on mechanisms of self-renewal and differentiation which preserve the stem cell population.

  • 00:05:00 - 00:10:00

    Stem cells vary in potency from totipotent, able to give rise to an entire organism, to unipotent, producing only their kind. Although adult stem cells primarily contribute to tissue regeneration, their in vitro capabilities include regenerative potential assessments like clonogenic assays and isolation by surface markers. Embryonic stem cells originate from the inner cell mass of a blastocyst, capable of generating all body cell types. However, differentiation demands precise conditions to avoid tumorigenesis or ethical controversies from embryonic sources, which are limited due to potential embryonic abuse.

  • 00:10:00 - 00:15:00

    Research led to the derivation and identification of stem cells capable of forming specialized neurons and play essential roles in brain development and functions. These stem cell types, however, exhibit restricted potencies like neural stem cells committed to CNS lineages. Achieving an undifferentiated state in vitro requires different environments for human versus mouse embryonic stem cells, both of which share regulatory mechanisms for pluripotency maintenance through essential factors and cell surface markers. These properties demonstrate their extensive, yet untapped potential.

  • 00:15:00 - 00:20:00

    The practical use of adult stem cells extends to human therapies such as bone marrow transplants for blood diseases. Aging impacts stem cell efficacies through accumulated DNA damage, affecting the self-renewal ability and overall viability. Stem cells sourced from amniotic fluid present advantages, circumventing ethical controversies tied to embryonic sources. These multipotent sources display regenerative potential for diverse tissue types, representing a promising active research area while bypassing destructive embryo use.

  • 00:20:00 - 00:25:00

    Adult stem cells, while limited in potency compared to embryonic stem cells, serve crucial roles in tissue repair. Techniques like somatic cell nuclear transfer and induced pluripotent stem cells offer alternatives with pluripotent capabilities by reprogramming adult cells into states analogous to embryonic stem cells, expanding therapeutic potential without ethical conflicts. These scientific breakthroughs led some researchers to shift focus from traditional embryonic stem cell methods to these innovative reprogramming techniques.

  • 00:25:00 - 00:30:00

    Induced pluripotent stem cells demonstrate similar properties to embryonic stem cells, including pluripotency and differentiation potential, albeit with distinct gene expression and epigenetic traits. Despite potential somatic memory effects, their regeneration promise continues fueling medical research. Stem cell therapy, spanning various medical fields, treats diseases by lowering symptoms and offering insights into cellular reactions. Such treatments necessitate immunosuppression and consider the undifferentiated stem cells' tumorigenic potential, juxtaposing biological benefits and therapy challenges.

  • 00:30:00 - 00:35:00

    Patent issues have dramatized stem cell research narratives. The Wisconsin Alumni Research Foundation holds essential embryonic stem cell patents, dictating industry and academic usage. Legal challenges ensue, reflecting continual discourse over intellectual property rights intersecting with scientific progress. Meanwhile, stem cell therapies explore broad applications, tackling conditions from neurodegenerative diseases to organ damage regeneration, guided by scientific optimism.

  • 00:35:00 - 00:40:00

    Ethics remain central, with debates over embryonic stem cell research juxtaposing moral viewpoints on life inception and therapeutic potential. Politically, embryonic stem cell funding and regulation attract discord as alternatives like induced pluripotent stem cells gain traction, promising less ethical complications. Yet, moral and religious stances foster opposition to embryo-involved methodologies, underlining this research's controversial dimension.

  • 00:40:00 - 00:45:57

    The future of stem cell research, while fraught with ethical and regulatory challenges, holds transformative potential for treating diseases and understanding human biology. Legislative perspectives on stem cell applications evolve amidst societal discourse, emphasizing scientific responsibility and medical advancement posited against moral beliefs. Endeavors explore novel methodologies that steer clear from contentious embryonic origins, aiming for broader therapeutic possibilities without ethical constraints.

Tampilkan lebih banyak

Peta Pikiran

Video Tanya Jawab

  • What are stem cells?

    Stem cells are cells that can differentiate into other types of cells and can also self-renew to produce more stem cells.

  • What are the main types of stem cells in mammals?

    There are two main types of stem cells in mammals: embryonic stem cells and adult stem cells.

  • How are stem cells used in medical treatments?

    Stem cells are used frequently in medical therapies such as bone marrow transplantation and are researched for their ability to regenerate damaged tissues.

  • What is the controversy surrounding stem cell research?

    The controversy mainly involves ethical concerns about the use and destruction of human embryos in embryonic stem cell research.

  • What are induced pluripotent stem cells (iPSCs)?

    Induced pluripotent stem cells are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state.

  • What ethical concerns are associated with embryonic stem cell research?

    The ethical concerns include the use and potential destruction of human embryos, which raises issues about the sanctity of human life.

  • What potential diseases could stem cell therapy help treat?

    Stem cell therapy is being researched for potential treatment of diseases like diabetes, Parkinson's, Alzheimer's, and spinal cord injuries.

  • How do stem cells contribute to tissue regeneration?

    Stem cells can differentiate into multiple cell types, which enables them to replenish and repair damaged tissues.

  • Are there alternatives to embryonic stem cells?

    Yes, alternatives include adult stem cells, induced pluripotent stem cells, and cells derived from amniotic fluid.

  • What is the significance of DNA repair in stem cells?

    DNA repair is crucial as it helps maintain stem cell functionality and plays a role in the aging process.

Lihat lebih banyak ringkasan video

Dapatkan akses instan ke ringkasan video YouTube gratis yang didukung oleh AI!
Teks
en
Gulir Otomatis:
  • 00:00:01
    [Music]
  • 00:00:19
    stem cells the secret to
  • 00:00:23
    immortality over the years there have
  • 00:00:25
    been many advances in the field of
  • 00:00:27
    medicine that have helped to extend the
  • 00:00:29
    longev ity of
  • 00:00:31
    mankind some of which would have been
  • 00:00:33
    considered to be too fantastic to
  • 00:00:35
    comprehend even just three decades ago
  • 00:00:38
    one of these modern Miracles are the
  • 00:00:40
    advances and strides taken in the area
  • 00:00:42
    of stem cell research some even consider
  • 00:00:46
    stem cells to be one of the possible
  • 00:00:48
    secrets of
  • 00:00:50
    mortality stem cells are cells that can
  • 00:00:53
    differentiate into other types of cells
  • 00:00:56
    and can also divide in self renewal to
  • 00:00:58
    produce more of the same type of stem
  • 00:01:01
    cells in mammals there are two broad
  • 00:01:04
    types of stem cells embryonic stem cells
  • 00:01:07
    which are isolated from the Inner Cell
  • 00:01:09
    mass of blasto cysts in early embryonic
  • 00:01:12
    development and adult stem cells which
  • 00:01:14
    are found in various tissues of fully
  • 00:01:16
    developed mammals in adult organisms
  • 00:01:20
    stem cells and progenitor cells act as a
  • 00:01:22
    repair system for the body replenishing
  • 00:01:25
    adult tissues in a developing embryo
  • 00:01:28
    stem cells can differentiate into all
  • 00:01:30
    the specialized cells ectoderm endoderm
  • 00:01:34
    and mism but also maintain the normal
  • 00:01:37
    turnover of regenerative organs such as
  • 00:01:39
    blood skin or intestinal tissues there
  • 00:01:43
    are three known accessible sources of
  • 00:01:45
    orious adult stem cells in humans bone
  • 00:01:48
    marrow adipose tissue and blood stem
  • 00:01:52
    cells can also be taken from umbilical
  • 00:01:54
    cord blood just after birth of all stem
  • 00:01:58
    cell therapy types autolus harvesting
  • 00:02:01
    involves the least
  • 00:02:02
    risk adult stem cells are frequently
  • 00:02:05
    used in various medical therapies such
  • 00:02:08
    as bone marrow
  • 00:02:09
    transplantation stem cells can now be
  • 00:02:12
    artificially grown and transformed and
  • 00:02:14
    differentiated into specialized cell
  • 00:02:16
    types with characteristics consistent
  • 00:02:18
    with cells of various tissues such as
  • 00:02:21
    muscles or nerves embryonic cell lines
  • 00:02:24
    and autologous embryonic stem cells
  • 00:02:26
    generated through somatic cell nuclear
  • 00:02:29
    transfer or dedifferentiation have also
  • 00:02:32
    been proposed as promising candidates
  • 00:02:34
    for future therapies Research into stem
  • 00:02:37
    cells grew out of findings by Ernest a
  • 00:02:39
    mccullock and James E till at the
  • 00:02:42
    University of Toronto in the
  • 00:02:45
    1960s the classical definition of a stem
  • 00:02:47
    cell requires that it possesses two
  • 00:02:50
    properties self-renewal the ability to
  • 00:02:53
    go through numerous cycles of cell
  • 00:02:55
    division while maintaining the
  • 00:02:57
    undifferentiated state potency
  • 00:03:00
    the capacity to differentiate into
  • 00:03:02
    specialized cell types in the strictest
  • 00:03:05
    sense this requires stem cells to be
  • 00:03:07
    either totipotent or plottin to be able
  • 00:03:10
    to give rise to any mature cell type
  • 00:03:13
    although multipotent or unipotent
  • 00:03:15
    progenitor cells are sometimes referred
  • 00:03:17
    to as stem cells apart from this it is
  • 00:03:21
    said that stem cell function is
  • 00:03:22
    regulated in a feedback mechanism two
  • 00:03:25
    mechanisms ensure that a stem cell
  • 00:03:27
    population is maintained
  • 00:03:30
    one obligatory asymmetric replication a
  • 00:03:33
    stem cell divides into one Mother cell
  • 00:03:36
    that is identical to the original stem
  • 00:03:38
    cell and another daughter cell that is
  • 00:03:41
    differentiated when a stem cell
  • 00:03:43
    self-renews it divides and does not
  • 00:03:45
    disrupt the undifferentiated state this
  • 00:03:48
    self-renewal demands control of cell
  • 00:03:51
    cycle as well as upkeep of multipotency
  • 00:03:53
    or pipany which all depends on the stem
  • 00:03:57
    cell two stochastic
  • 00:04:00
    differentiation when one stem cell
  • 00:04:02
    develops into two differentiated
  • 00:04:04
    daughter cells another stem cell
  • 00:04:06
    undergoes mitosis and produces two stem
  • 00:04:09
    cells identical to the original
  • 00:04:12
    pluripotent embryonic stem cells
  • 00:04:14
    originate as Inner Cell mass or ICM for
  • 00:04:17
    short cells within a blast assy these
  • 00:04:21
    stem cells can become any tissue in the
  • 00:04:23
    body excluding a placenta only cells
  • 00:04:26
    from an earlier stage of the embryo
  • 00:04:28
    known as the marula AR totipotent able
  • 00:04:31
    to become all tissues in the body and
  • 00:04:33
    the extra embryonic
  • 00:04:36
    placenta human embryonic stem cells a
  • 00:04:40
    stem cell colonies that are not yet
  • 00:04:42
    differentiated B nerve cells an example
  • 00:04:46
    of a cell type after
  • 00:04:48
    differentiation potency specifies the
  • 00:04:51
    differentiation potential meaning the
  • 00:04:53
    potential to differentiate into
  • 00:04:55
    different cell types of the stem cell
  • 00:04:58
    totipotent or omnipotent stem cells can
  • 00:05:00
    differentiate into embryonic and
  • 00:05:02
    extraembryonic cell types such cells can
  • 00:05:05
    construct a complete viable organism
  • 00:05:08
    these cells are produced from the fusion
  • 00:05:10
    of an egg and a sperm cell cells
  • 00:05:13
    produced by the first few divisions of
  • 00:05:15
    the fertilized egg are also
  • 00:05:18
    totipotent pluripotent stem cells are
  • 00:05:20
    the descendants of totipotent cells and
  • 00:05:23
    can differentiate into nearly all cells
  • 00:05:26
    cells derived from any of the three germ
  • 00:05:28
    layers
  • 00:05:30
    multipotent stem cells can differentiate
  • 00:05:32
    into a number of cell types but only
  • 00:05:35
    those of a closely related family of
  • 00:05:37
    cells oligopotent stem cells can
  • 00:05:40
    differentiate into only a few cell types
  • 00:05:43
    such as lymphoid or myoid stem cells
  • 00:05:46
    unipotent cells can produce only one
  • 00:05:49
    cell type their own but have the
  • 00:05:51
    property of self-renewal which
  • 00:05:53
    distinguishes them from non- stem cells
  • 00:05:55
    such as progenitor cells which cannot
  • 00:05:58
    self-renew in in practice stem cells are
  • 00:06:01
    identified by whether they can
  • 00:06:02
    regenerate tissue for example the
  • 00:06:05
    defining test for bone marrow or
  • 00:06:07
    hematopoetic stem cells or hsc's for
  • 00:06:10
    short is the ability to transplant the
  • 00:06:13
    cells and save an individual without
  • 00:06:16
    hsc's this demonstrates that the cells
  • 00:06:18
    can produce new blood cells over a long
  • 00:06:21
    term it should also be possible to
  • 00:06:23
    isolate stem cells from the transplanted
  • 00:06:26
    individual which can themselves be
  • 00:06:28
    transplanted into another IND individual
  • 00:06:30
    without hsc's demonstrating that the
  • 00:06:32
    stem cell was able to
  • 00:06:35
    self-renew properties of stem cells can
  • 00:06:37
    be Illustrated in vitro using methods
  • 00:06:40
    such as clonogenic assays in which
  • 00:06:42
    single cells are assessed for their
  • 00:06:44
    ability to differentiate and
  • 00:06:46
    self-renew stem cells can also be
  • 00:06:49
    isolated by their possession of a
  • 00:06:51
    distinctive set of cell surface
  • 00:06:53
    markers however invitro culture
  • 00:06:56
    conditions can alter the behavior of
  • 00:06:58
    cells making it unclear whether the
  • 00:07:00
    cells shall behave in a similar manner
  • 00:07:02
    in
  • 00:07:03
    Vivo there is considerable debate as to
  • 00:07:06
    whether some proposed adult cell
  • 00:07:08
    populations are truly stem
  • 00:07:10
    cells embryonic stem cells also known as
  • 00:07:13
    esc's are the cells of the Inner Cell
  • 00:07:16
    mass of a blast assyst formed prior to
  • 00:07:19
    implantation in the uterus in human
  • 00:07:22
    embryonic development the blasticus
  • 00:07:24
    stage is reached 4 to 5 days after
  • 00:07:27
    fertilization at which time it can of 50
  • 00:07:30
    to 150 cells esc's are pluripotent and
  • 00:07:35
    give rise during development to all
  • 00:07:37
    derivatives of the three germ layers
  • 00:07:39
    ectoderm endoderm and mism in other
  • 00:07:42
    words they can develop into each of the
  • 00:07:44
    more than 200 cell types of the adult
  • 00:07:47
    body when given sufficient and necessary
  • 00:07:49
    stimulation for a specific cell type
  • 00:07:52
    they do not contribute to the extra
  • 00:07:54
    embrionic membranes or to the
  • 00:07:57
    placenta during embryonic development
  • 00:08:00
    the cells of the Inner Cell Mass
  • 00:08:01
    continuously divide and become more
  • 00:08:04
    specialized for example a portion of the
  • 00:08:06
    ectoderm in the dorsal part of the
  • 00:08:08
    embryo specializes as neurectoderm which
  • 00:08:11
    will become the future central nervous
  • 00:08:14
    system later in development neurulation
  • 00:08:17
    causes the neurectoderm to form the
  • 00:08:19
    neural tube at the neural tube stage the
  • 00:08:23
    anterior portion undergoes eniz to
  • 00:08:26
    generate or pattern the basic form of
  • 00:08:28
    the brain
  • 00:08:30
    at this stage of development the
  • 00:08:31
    principal cell type of the CNS is
  • 00:08:33
    considered a neural stem
  • 00:08:36
    cell the neural stem cells self-renew
  • 00:08:39
    and at some point transition into radial
  • 00:08:42
    gal progenitor cells also known as
  • 00:08:45
    rgps early formed rgps self-renew by
  • 00:08:49
    symmetrical division to form a reservoir
  • 00:08:51
    group of progenitor
  • 00:08:53
    cells these cells transition to a
  • 00:08:55
    neurogenic State and start to divide
  • 00:08:57
    asymmetrically to produce a large
  • 00:08:59
    diversity of many different neuron types
  • 00:09:02
    each with unique gene expression
  • 00:09:05
    morphological and functional
  • 00:09:07
    characteristics the process of
  • 00:09:09
    generating neurons from radial gal cells
  • 00:09:12
    is called
  • 00:09:13
    neurogenesis the radial gal cell has a
  • 00:09:16
    distinctive bipolar morphology with
  • 00:09:18
    highly elongated processes spanning the
  • 00:09:21
    thickness of the neural tube wall it
  • 00:09:24
    shares some gal characteristics most
  • 00:09:26
    notably the expression of gal fibular
  • 00:09:28
    acidic protein or gfap for
  • 00:09:32
    short the radial gal cell is the primary
  • 00:09:35
    neural stem cell of the developing
  • 00:09:37
    vertebrate CNS and its cell body resides
  • 00:09:40
    in the ventricular Zone adjacent to the
  • 00:09:43
    developing ventricular system neural
  • 00:09:46
    stem cells are committed to the neuronal
  • 00:09:48
    lineages such as neurons astrocytes and
  • 00:09:52
    oligodendrocytes and thus their potency
  • 00:09:54
    is
  • 00:09:55
    restricted nearly all research to date
  • 00:09:58
    has made use of Mouse embryonic stem
  • 00:10:00
    cells or human embryonic stem cells
  • 00:10:03
    derived from the early Inner Cell Mass
  • 00:10:06
    both have the essential stem cell
  • 00:10:08
    characteristics yet they require very
  • 00:10:10
    different environments in order to
  • 00:10:11
    maintain an undifferentiated State Mouse
  • 00:10:15
    embrionic stem cells are grown on a
  • 00:10:17
    layer of gelatin as an extracellular
  • 00:10:19
    Matrix for support and require the
  • 00:10:21
    presence of leukemia inhibitory factor
  • 00:10:24
    in serum media a drug cocktail
  • 00:10:27
    containing Inhibitors called 2i has also
  • 00:10:30
    been shown to maintain pipany in stem
  • 00:10:33
    cell
  • 00:10:34
    culture human esc's are grown on a feed
  • 00:10:37
    delayer of mouse embryonic fibr blasts
  • 00:10:40
    and require the presence of basic fibr
  • 00:10:42
    blast growth factor without optimal
  • 00:10:45
    culture conditions or genetic
  • 00:10:47
    manipulation embryonic stem cells will
  • 00:10:49
    rapidly
  • 00:10:51
    differentiate a human embryonic stem
  • 00:10:53
    cell is also defined by the expression
  • 00:10:55
    of several transcription factors and
  • 00:10:58
    cell surface protein
  • 00:11:00
    the transcription factors OCT 4 nanog
  • 00:11:03
    and Sox 2 form the core regulatory
  • 00:11:06
    Network that ensures the suppression of
  • 00:11:08
    genes that lead to differentiation and
  • 00:11:10
    the maintenance of
  • 00:11:12
    pluripotency the cell surface antigens
  • 00:11:14
    most commonly used to identify hes cells
  • 00:11:18
    are the glycolipids stage specific
  • 00:11:20
    embryonic antigen 3 and four and the
  • 00:11:22
    Keratin sulfate antigens TR 160 and TR
  • 00:11:27
    181
  • 00:11:29
    the molecular definition of a stem cell
  • 00:11:31
    includes many more proteins and
  • 00:11:33
    continues to be a topic of
  • 00:11:36
    research by using human embryonic stem
  • 00:11:39
    cells to produce specialized cells like
  • 00:11:41
    nerve cells or heart cells in the lab
  • 00:11:44
    scientists can gain access to adult
  • 00:11:46
    human cells without taking tissue from
  • 00:11:49
    patients they can then study these
  • 00:11:51
    specialized adult cells in detail to try
  • 00:11:54
    to discern complications of diseases or
  • 00:11:56
    to study cell reactions to propos new
  • 00:11:59
    drugs because of their combined
  • 00:12:02
    abilities of unlimited expansion and
  • 00:12:04
    pipany embryonic stem cells remain a
  • 00:12:07
    theoretically potential source for
  • 00:12:09
    regenerative medicine and tissue
  • 00:12:11
    replacement after injury or disease
  • 00:12:14
    however there are currently no approved
  • 00:12:16
    treatments using ES cells the first
  • 00:12:19
    human trial was approved by the US Food
  • 00:12:21
    and Drug Administration in January 2009
  • 00:12:25
    however the human trial was not
  • 00:12:27
    initiated until October the 13th 2010 in
  • 00:12:30
    Atlanta for spinal cord injury research
  • 00:12:33
    on November 14th 2011 the company
  • 00:12:36
    conducting the trial Geron Corporation
  • 00:12:39
    announced that it will discontinue
  • 00:12:41
    further development of its stem cell
  • 00:12:43
    programs differentiating es cells into
  • 00:12:46
    usable cells while avoiding transplant
  • 00:12:48
    rejection are just a few of the hurdles
  • 00:12:50
    that embryonic stem cell researchers
  • 00:12:52
    still face embryonic stem cells being
  • 00:12:56
    pluripotent require specific signals for
  • 00:12:59
    direct differentiation if injected
  • 00:13:01
    directly into another body es cells will
  • 00:13:04
    differentiate into many different types
  • 00:13:06
    of cells causing a
  • 00:13:08
    Teratoma ethical considerations
  • 00:13:10
    regarding the use of unborn human tissue
  • 00:13:13
    are another reason for the lack of
  • 00:13:14
    approved treatments using embryonic stem
  • 00:13:17
    cells many nations currently have
  • 00:13:20
    moratoria or limitations on either human
  • 00:13:22
    es cell research or the production of
  • 00:13:24
    new human es cell
  • 00:13:27
    lines the Primitive stem cell cells
  • 00:13:29
    located in the organs of fetuses are
  • 00:13:31
    referred to as fetal stem cells there
  • 00:13:34
    are two types of fetal stem cells fetal
  • 00:13:37
    proper stem cells come from the tissue
  • 00:13:39
    of the fetus proper and are generally
  • 00:13:41
    obtained after an abortion these stem
  • 00:13:44
    cells are not Immortal but have a high
  • 00:13:46
    level of division and are
  • 00:13:48
    multipotent extraembryonic fetal stem
  • 00:13:51
    cells come from extra embrionic
  • 00:13:53
    membranes and are generally not
  • 00:13:55
    distinguished from adult stem cells
  • 00:13:58
    these stem cells are acquired after
  • 00:14:00
    birth they are not Immortal but have a
  • 00:14:03
    high level of cell division and are
  • 00:14:05
    pluripotent stem cell division and
  • 00:14:09
    differentiation adult stem cells also
  • 00:14:11
    called somatic stem cells are stem cells
  • 00:14:14
    which maintain and repair the tissue in
  • 00:14:16
    which they are found they can be found
  • 00:14:19
    in children as well as adults there are
  • 00:14:22
    three known accessible sources of
  • 00:14:24
    autologous adult stem cells in
  • 00:14:26
    humans bone marrow which require
  • 00:14:29
    extraction by harvesting that is
  • 00:14:31
    drilling into bone typically the femur
  • 00:14:34
    or iliac crest fat cells known as
  • 00:14:37
    adipose tissue which requires extraction
  • 00:14:40
    by
  • 00:14:41
    liposuction blood which requires
  • 00:14:43
    extraction through a feris wherein blood
  • 00:14:46
    is drawn from the donor similar to a
  • 00:14:48
    blood donation and pass through a
  • 00:14:50
    machine that extracts the stem cells and
  • 00:14:52
    returns other portions of the blood to
  • 00:14:54
    the
  • 00:14:54
    donor stem cells can also be taken from
  • 00:14:57
    umbilical cord blood just after birth of
  • 00:15:01
    all stem cell types autolus harvesting
  • 00:15:03
    involves the least Risk by definition
  • 00:15:07
    autolus cells are obtained from one's
  • 00:15:09
    own body just as one may Bank his or her
  • 00:15:11
    own blood for elective surgical
  • 00:15:14
    procedures plent adult stem cells are
  • 00:15:17
    rare and generally small in number but
  • 00:15:20
    they can be found in umbilical cord
  • 00:15:21
    blood and other
  • 00:15:23
    tissues bone marrow is a rich source of
  • 00:15:25
    adult stem cells which have been used in
  • 00:15:28
    treating several conditions including
  • 00:15:30
    liver curosis chronic limb ischemia and
  • 00:15:33
    endstage heart failure the quantity of
  • 00:15:36
    bone marrow stem cells declines with age
  • 00:15:38
    and is greater in males than females
  • 00:15:41
    during reproductive years much adult
  • 00:15:44
    stem cell researched to date has aimed
  • 00:15:46
    to characterize their potency and
  • 00:15:48
    self-renewal
  • 00:15:49
    capabilities DNA damage accumulates with
  • 00:15:52
    age in both stem cells and the cells
  • 00:15:55
    that comprise the stem cell environment
  • 00:15:57
    this accumulation is is considered to be
  • 00:15:59
    responsible at least in part for
  • 00:16:02
    increasing stem cell dysfunction with
  • 00:16:04
    aging known as the DNA damage Theory of
  • 00:16:07
    Aging the DNA damage Theory of Aging
  • 00:16:11
    proposes that aging is a consequence of
  • 00:16:13
    unrepaired accumulation of naturally
  • 00:16:15
    occurring DNA damages damage in this
  • 00:16:18
    context is a DNA alteration that has an
  • 00:16:21
    abnormal structure although both
  • 00:16:24
    mitochondrial and nuclear DNA damage can
  • 00:16:26
    contribute to aging nuclear DNA DNA is
  • 00:16:29
    the main subject of this
  • 00:16:31
    analysis nuclear DNA damage can
  • 00:16:34
    contribute to aging either indirectly by
  • 00:16:36
    increasing apoptosis or Celia cence or
  • 00:16:39
    directly by increasing cell
  • 00:16:42
    dysfunction several review articles have
  • 00:16:45
    shown that deficient DNA repair allowing
  • 00:16:47
    greater accumulation of DNA damages
  • 00:16:50
    causes premature aging and that
  • 00:16:52
    increased DNA repair facilitates greater
  • 00:16:55
    longevity Mouse models of nucleotide
  • 00:16:58
    Excision repair syndromes reveal a
  • 00:17:00
    striking correlation between the degree
  • 00:17:02
    to which specific DNA repair pathways
  • 00:17:05
    are compromised and the severity of
  • 00:17:07
    accelerated aging strongly suggesting a
  • 00:17:10
    causal
  • 00:17:11
    relationship human population studies
  • 00:17:13
    show that single nucleotide
  • 00:17:15
    polymorphisms in DNA repair genes
  • 00:17:18
    causing upregulation of their expression
  • 00:17:21
    correlate with increases in
  • 00:17:23
    longevity Lombard etal compiled a
  • 00:17:26
    lengthy list of mouse mutation models
  • 00:17:28
    with patholog IC features of premature
  • 00:17:30
    aging all caused by different DNA repair
  • 00:17:33
    defects freas and de magal haes
  • 00:17:36
    presented a comprehensive review and
  • 00:17:38
    Appraisal of the DNA damaged Theory of
  • 00:17:40
    Aging including a detailed analysis of
  • 00:17:43
    many forms of evidence linking DNA
  • 00:17:45
    damage to aging as an example they
  • 00:17:48
    described a study showing that
  • 00:17:50
    centenarians of 100 to7 years of age had
  • 00:17:54
    higher levels of two DNA repair enzymes
  • 00:17:57
    pop 1 and K u70 than general population
  • 00:18:01
    old individuals of 69 to 75 years of age
  • 00:18:05
    their analysis supported the hypothesis
  • 00:18:07
    that improved DNA repair leads to longer
  • 00:18:11
    lifespan overall they concluded that
  • 00:18:13
    while the complexity of responses to DNA
  • 00:18:16
    damage remains only partly understood
  • 00:18:18
    the idea that DNA damage accumulation
  • 00:18:21
    with age is the primary cause of Aging
  • 00:18:23
    remains an intuitive and Powerful
  • 00:18:26
    one in humans and other mammals DNA
  • 00:18:29
    damage occurs frequently and DNA repair
  • 00:18:32
    processes have evolved to
  • 00:18:34
    compensate in estimates made for mice
  • 00:18:37
    DNA lesions occur on average 25 to 115
  • 00:18:41
    times per minute in each cell or about
  • 00:18:44
    36,000 to 160,000 per cell per day some
  • 00:18:50
    DNA damage May remain in any cell
  • 00:18:52
    despite the action of repair
  • 00:18:54
    processes the accumulation of unrepaired
  • 00:18:57
    DNA damage is more prevalent in certain
  • 00:18:59
    types of cells particularly in
  • 00:19:02
    non-replicating or slowly replicating
  • 00:19:04
    cells such as cells in the brain
  • 00:19:06
    skeletal and cardiac muscle most adult
  • 00:19:10
    stem cells are lineage restricted
  • 00:19:12
    multipotent and are generally referred
  • 00:19:15
    to by their tissue origin mimal stem
  • 00:19:18
    cell adpost derived stem cell
  • 00:19:20
    endothelium stem cell Dental pulp stem
  • 00:19:23
    cell
  • 00:19:25
    Etc mu cells multi-lineage differenti I
  • 00:19:28
    ating stress enduring cells are a
  • 00:19:30
    recently discovered plottin stem cell
  • 00:19:33
    type found in multiple adult tissues
  • 00:19:36
    including adipose dermal fibr blasts and
  • 00:19:39
    bone marrow while rare Muse cells are
  • 00:19:42
    identifiable by their expression of
  • 00:19:45
    ssa3 a marker for undifferentiated stem
  • 00:19:48
    cells and general meenal stem cells
  • 00:19:51
    markers such as
  • 00:19:53
    cd105 when subjected to single cell
  • 00:19:56
    suspension culture the cells will
  • 00:19:58
    generate clusters that are similar to
  • 00:20:00
    embryoid bodies in morphology as well as
  • 00:20:03
    gene expression including canonical
  • 00:20:05
    pipany markers OCT 4 sock 2 and
  • 00:20:09
    nanog adult stem cell treatments have
  • 00:20:12
    been successfully used for many years to
  • 00:20:14
    treat leukemia and related bone and
  • 00:20:16
    blood cancers through bone marrow
  • 00:20:19
    transplants adult stem cells are also
  • 00:20:21
    used in veterinary medicine to treat
  • 00:20:24
    tendon and ligament injuries in
  • 00:20:26
    horses the use of adult stem cells in
  • 00:20:29
    research and therapy is not as
  • 00:20:31
    controversial as the use of embryonic
  • 00:20:33
    stem cells because the production of
  • 00:20:35
    adult stem cells does not require the
  • 00:20:37
    destruction of an
  • 00:20:38
    embryo additionally in instances where
  • 00:20:41
    adult stem cells are obtained from the
  • 00:20:43
    intended recipient an autographed the
  • 00:20:46
    risk of rejection is essentially
  • 00:20:48
    non-existent consequently more US
  • 00:20:51
    Government funding is being provided for
  • 00:20:53
    adults them cell
  • 00:20:55
    research with the increasing demand of
  • 00:20:58
    human adult adult stem cells for both
  • 00:20:59
    research and clinical purposes typically
  • 00:21:02
    1 to 5 million cells per kilo of body
  • 00:21:05
    weight are required per treatment it
  • 00:21:07
    becomes of utmost importance to bridge
  • 00:21:09
    the gap between the need to expand the
  • 00:21:11
    cells in vitro and the capability of
  • 00:21:14
    harnessing the factors underlying
  • 00:21:16
    replicative
  • 00:21:17
    senance adult stem cells are known to
  • 00:21:20
    have a limited lifespan in vitro and to
  • 00:21:22
    enter replicative senance almost
  • 00:21:24
    undetectably upon starting in vitro
  • 00:21:27
    culturing
  • 00:21:29
    multipotent stem cells are also found in
  • 00:21:31
    amniotic fluid these stem cells are very
  • 00:21:35
    active expand extensively without
  • 00:21:37
    feeders and are not
  • 00:21:39
    tumorogenic amniotic stem cells are
  • 00:21:42
    multipotent and can differentiate in
  • 00:21:44
    cells of adipogenic osteogenic myogenic
  • 00:21:48
    endothelial hepatic and also neuronal
  • 00:21:51
    lines amniotic stem cells are a topic of
  • 00:21:54
    active
  • 00:21:56
    research use of stem cells from amniotic
  • 00:21:59
    fluid overcomes the ethical objections
  • 00:22:01
    to using human embryos as a source of
  • 00:22:04
    cells Roman Catholic teaching forbids
  • 00:22:07
    the use of embryonic stem cells in
  • 00:22:09
    experimentation accordingly the Vatican
  • 00:22:11
    newspaper OB servator Romano called
  • 00:22:15
    amniotic stem cells the future of
  • 00:22:17
    medicine it is possible to collect
  • 00:22:20
    amniotic stem cells for donors or for
  • 00:22:22
    autologous use the first US amniotic
  • 00:22:25
    stem cells Bank was opened in 2009 9 in
  • 00:22:29
    Medford Massachusetts by biocells Center
  • 00:22:32
    Corporation and collaborates with
  • 00:22:34
    various hospitals and universities all
  • 00:22:36
    over the world adult stem cells have
  • 00:22:39
    limitations with their potency unlike
  • 00:22:41
    embryonic stem cells known as esc's they
  • 00:22:44
    are not able to differentiate into cells
  • 00:22:47
    from all three germ layers as such they
  • 00:22:50
    are deemed
  • 00:22:51
    multipotent however reprogramming allows
  • 00:22:54
    for the creation of plottin cells
  • 00:22:56
    induced plottin stem cells from adult
  • 00:22:59
    cells these are not adult stem cells but
  • 00:23:02
    adult cells reprogrammed to give rise to
  • 00:23:05
    cells with plottin
  • 00:23:07
    capabilities using genetic reprogramming
  • 00:23:10
    with protein transcription factors
  • 00:23:12
    plottin stem cells with ESC like
  • 00:23:14
    capabilities have been derived the first
  • 00:23:17
    demonstration of induced plottin stem
  • 00:23:19
    cells was conducted by shinya yamanaka
  • 00:23:22
    and his colleagues at Kyoto University
  • 00:23:25
    they used the transcription factors OCT
  • 00:23:27
    3 and 4 sock 2 C myc and klf4 to
  • 00:23:33
    reprogram Mal's fiberblast cells into
  • 00:23:35
    plottin cells subsequent work used these
  • 00:23:39
    factors to induce pipany in human
  • 00:23:42
    fiberblast cells yuning Yu James
  • 00:23:45
    Thompson and their colleagues at the
  • 00:23:47
    University of Wisconsin Madison used a
  • 00:23:50
    different set of factors OG for socks 2
  • 00:23:53
    nanog and Lin 28 and carried out their
  • 00:23:56
    experiments using cells from Human
  • 00:23:59
    foreskin however they were able to
  • 00:24:01
    replicate yamanaka's finding that
  • 00:24:03
    inducing pipany in human cells was
  • 00:24:07
    possible induced plottin stem cells
  • 00:24:10
    known as ipscs for short differ from
  • 00:24:13
    embryonic stem cells they share many
  • 00:24:16
    similar properties such as pipany and
  • 00:24:19
    differentiation potential the expression
  • 00:24:21
    of pipany genes epigenetic patterns
  • 00:24:24
    embryoid body and teratoma formation and
  • 00:24:27
    viable Chimera formation but there are
  • 00:24:30
    many differences within these
  • 00:24:32
    properties the chromatin of ipscs
  • 00:24:35
    appears to be more closed or methylated
  • 00:24:38
    than that of
  • 00:24:39
    esc's similarly the gene expression
  • 00:24:42
    pattern between esc's and ipscs or even
  • 00:24:46
    ipscs sourced from different Origins
  • 00:24:49
    there are thus questions about the
  • 00:24:50
    completeness of reprogramming and the
  • 00:24:53
    sematic memory of induced ppant stem
  • 00:24:55
    cells despite this inducing a adult
  • 00:24:58
    cells to be pipitantv
  • 00:25:01
    as a result of the success of these
  • 00:25:04
    experiments Ian wilou who helped create
  • 00:25:07
    the first cloned animal Dolly the sheep
  • 00:25:09
    has announced that he will abandon
  • 00:25:11
    sematic cell nuclear transfer as an
  • 00:25:13
    Avenue of research furthermore induced
  • 00:25:16
    pluripotent stem cells provide several
  • 00:25:19
    therapeutic advantages like esc's they
  • 00:25:21
    are pluripotent they thus have great
  • 00:25:24
    differentiation potential theoretically
  • 00:25:27
    they could produce any sub within the
  • 00:25:28
    human body if reprogramming to pipany
  • 00:25:31
    was
  • 00:25:32
    complete moreover unlike esc's they
  • 00:25:36
    potentially could allow doctors to
  • 00:25:37
    create a pipan stem cell line for each
  • 00:25:40
    individual patient Frozen blood samples
  • 00:25:43
    can be used as a valuable source of
  • 00:25:45
    induced pipitantv
  • 00:25:58
    use therapeutically ipscs hold create
  • 00:26:01
    potential for future use in medical
  • 00:26:03
    treatment and
  • 00:26:05
    research to ensure self-renewal stem
  • 00:26:08
    cells undergo two types of cell division
  • 00:26:11
    symmetric division gives rise to two
  • 00:26:14
    identical daughter cells both endowed
  • 00:26:16
    with stem cell properties asymmetric
  • 00:26:19
    division on the other hand produces only
  • 00:26:21
    one stem cell and a progenitor cell with
  • 00:26:23
    limited self-renewal potential
  • 00:26:26
    progenitors can go through several round
  • 00:26:28
    of cell division before terminally
  • 00:26:30
    differentiating into a mature cell it is
  • 00:26:33
    possible that the molecular distinction
  • 00:26:35
    between symmetric and asymmetric
  • 00:26:37
    divisions lies in differential
  • 00:26:39
    segregation of cell membrane proteins
  • 00:26:41
    such as receptors between the daughter
  • 00:26:44
    cells an alternative theory is that stem
  • 00:26:47
    cells remain undifferentiated due to
  • 00:26:50
    environmental cues in their particular
  • 00:26:52
    Niche stem cells differentiate when they
  • 00:26:55
    leave that Niche or no longer receive
  • 00:26:57
    those signals
  • 00:26:59
    studies in dropil garum have identified
  • 00:27:02
    the signals decapentaplegic and
  • 00:27:04
    adherence Junctions that prevent jarum
  • 00:27:07
    stem cells from
  • 00:27:08
    differentiating stem cell therapy is the
  • 00:27:11
    use of stem cells to treat or prevent a
  • 00:27:13
    disease or condition bone marrow
  • 00:27:16
    transplant is a form of stem cell
  • 00:27:18
    therapy that has been used for many
  • 00:27:19
    years without
  • 00:27:21
    controversy stem cell treatments May
  • 00:27:24
    lower symptoms of the disease or
  • 00:27:26
    condition that's being treated the
  • 00:27:28
    lowering of symptoms may allow patients
  • 00:27:30
    to reduce the drug intake of the disease
  • 00:27:32
    or condition stem cell treatment may
  • 00:27:35
    also provide knowledge for society to
  • 00:27:37
    further stem cell understanding and
  • 00:27:39
    future
  • 00:27:40
    treatments stem cell treatments may
  • 00:27:42
    require immunosuppression because of a
  • 00:27:44
    requirement for radiation before the
  • 00:27:46
    transplant to remove the person's
  • 00:27:48
    previous cells or because the patient's
  • 00:27:51
    immune system May Target the stem cells
  • 00:27:54
    one approach to avoid the second
  • 00:27:56
    possibility is to use stem cells from
  • 00:27:57
    the same patient who is being
  • 00:28:00
    treated pipany in certain stem cells
  • 00:28:03
    could also make it difficult to obtain a
  • 00:28:05
    specific cell type it is also difficult
  • 00:28:08
    to obtain the exact cell type needed
  • 00:28:10
    because not all cells in a population
  • 00:28:12
    differentiate
  • 00:28:14
    uniformly undifferentiated cells can
  • 00:28:16
    create tissues other than desired
  • 00:28:19
    types some stem cells form tumors after
  • 00:28:22
    transplantation pipany is linked to
  • 00:28:25
    tumor formation especially in embryonic
  • 00:28:27
    stem cell cells fetal proper stem cells
  • 00:28:30
    induced plur repetent stem cells fetal
  • 00:28:33
    proper stem cells form tumors despite
  • 00:28:36
    multipotency
  • 00:28:37
    some of the fundamental patents covering
  • 00:28:40
    human embryonic stem cells are owned by
  • 00:28:42
    the Wisconsin alumni Research Foundation
  • 00:28:45
    known as Warf they are patents 5843
  • 00:28:50
    780
  • 00:28:53
    62086 and 7029 913 invent by James A
  • 00:28:59
    Thompson Warf does not enforce these
  • 00:29:02
    patents against academic scientists but
  • 00:29:04
    does enforce them against
  • 00:29:07
    companies in 2006 a request for the US
  • 00:29:11
    PTO the US patent and trademark office
  • 00:29:14
    to reexamine the three patents was filed
  • 00:29:16
    by the public patent foundation on
  • 00:29:18
    behalf of its client the nonprofit
  • 00:29:20
    patent Watchdog group consumer Watchdog
  • 00:29:23
    formerly the foundation for taxpayer and
  • 00:29:25
    consumer rights in the reexamination
  • 00:29:29
    process which involves several rounds of
  • 00:29:31
    discussion between the US PTO and the
  • 00:29:33
    parties the US PTO initially agreed with
  • 00:29:36
    consumer Watchdog and rejected all the
  • 00:29:38
    claims in all three
  • 00:29:40
    patents however in response Warf amended
  • 00:29:43
    the claims of all three patents to make
  • 00:29:45
    them more narrow and in 2008 the US PTO
  • 00:29:49
    found the amended claims in all three
  • 00:29:51
    patents to be
  • 00:29:52
    patentable the decision on one of the
  • 00:29:55
    patents was appealable while the
  • 00:29:56
    decisions on the other two were not
  • 00:29:59
    consumer Watchdog appealed the granting
  • 00:30:01
    of the 913 patent to the uspto's board
  • 00:30:04
    of patent appeals and interferences
  • 00:30:07
    which granted the appeal and in 2010 the
  • 00:30:10
    bpai decided that the amended claims of
  • 00:30:12
    the 913 patent were not
  • 00:30:16
    patentable however WF was able to reopen
  • 00:30:19
    prosecution of the case and did so
  • 00:30:21
    amending the claims of the 913 patent
  • 00:30:23
    again to make them more narrow and in
  • 00:30:26
    January 2013 the amend claims were
  • 00:30:30
    allowed in July 2013 Consumer Watchdog
  • 00:30:34
    announced that it would appeal the
  • 00:30:35
    decision to allow the claims of the 913
  • 00:30:38
    patent to the US court of appeals for
  • 00:30:40
    the federal circuit the federal appeals
  • 00:30:42
    court that his patent cases at a hearing
  • 00:30:45
    in December 2013 the cafc raised the
  • 00:30:49
    question of whether consumer Watchdog
  • 00:30:51
    had legal standing to appeal the case
  • 00:30:53
    could not proceed until the issue was
  • 00:30:55
    resolved
  • 00:30:58
    diseases and conditions where stem cell
  • 00:31:00
    treatment is being investigated include
  • 00:31:03
    diabetes rheumatoid arthritis
  • 00:31:06
    Parkinson's disease Alzheimer's disease
  • 00:31:10
    osteoarthritis stroke and traumatic
  • 00:31:12
    brain injury repair learning disability
  • 00:31:15
    due to congenital disorder spinal cord
  • 00:31:18
    injury repair heart
  • 00:31:21
    inunction anti-cancer treatments
  • 00:31:24
    boldness reversal replace missing teeth
  • 00:31:27
    repair repair hearing restore vision and
  • 00:31:30
    repair damage to the cornea amyotrophic
  • 00:31:33
    lateral sclerosis Crohn's disease wound
  • 00:31:37
    healing male infertility due to absence
  • 00:31:40
    of spermatogonial stem cells in recent
  • 00:31:44
    studies scientists have found a way to
  • 00:31:46
    solve this problem by reprogramming a
  • 00:31:48
    cell and turning it into a spermato Zone
  • 00:31:51
    other Studies have proven the
  • 00:31:52
    restoration of spermatogenesis by
  • 00:31:55
    introducing human ipsc cells in mice
  • 00:31:58
    testicles this could mean the end of aus
  • 00:32:02
    spermia female infertility oyes made
  • 00:32:06
    from embryonic stem cells recently
  • 00:32:09
    scientists have found the ovarian stem
  • 00:32:11
    cells a rare type of cells found in the
  • 00:32:13
    ovary it is not clear their existence
  • 00:32:16
    yet but the impact it could have are
  • 00:32:18
    Limitless it could be used as a
  • 00:32:20
    treatment not only for infertility but
  • 00:32:23
    also for premature ovarian
  • 00:32:26
    insufficiency as with any radical
  • 00:32:28
    advances in science the research into
  • 00:32:30
    stem cell treatment has not been without
  • 00:32:33
    controversy the stem cell controversy is
  • 00:32:35
    the consideration of the ethics of
  • 00:32:37
    research involving the development use
  • 00:32:39
    and destruction of human embryos most
  • 00:32:42
    commonly this controvery focuses on
  • 00:32:44
    embryonic stem cells not all stem cell
  • 00:32:47
    research involves human embryos for
  • 00:32:50
    example adult stem cells amniotic stem
  • 00:32:53
    cells and induced plottin stem cells do
  • 00:32:56
    not involve creating using or destroying
  • 00:32:59
    human embryos and thus are minimally if
  • 00:33:02
    at all
  • 00:33:03
    controversial many less controversial
  • 00:33:06
    sources of acquiring stem cells include
  • 00:33:08
    using cells from the umbilical cord
  • 00:33:10
    breast milk and bone marrow which are
  • 00:33:12
    not
  • 00:33:14
    plottin great levels of success and
  • 00:33:17
    potential have been realized from
  • 00:33:18
    research using adult stem cells in early
  • 00:33:22
    2009 the FDA approved the first human
  • 00:33:25
    clinical trials using embryonic stem
  • 00:33:27
    cells C only cells from an embryo at the
  • 00:33:30
    morula stage or earlier are truly
  • 00:33:32
    totipotent meaning that they are able to
  • 00:33:34
    form all cell types including placental
  • 00:33:37
    cells adult stem cells are generally
  • 00:33:40
    limited to differentiating into
  • 00:33:42
    different cell types of their tissue of
  • 00:33:44
    origin however some evidence suggests
  • 00:33:47
    that adult stem cell plasticity may
  • 00:33:49
    exist increasing the number of cell
  • 00:33:51
    types a given adult stem cell can
  • 00:33:54
    become many of the debates surrounding
  • 00:33:57
    human EMB I IC stem cells concern issues
  • 00:33:59
    such as what restriction should be made
  • 00:34:01
    on studies using these types of cells at
  • 00:34:05
    what point does one consider life to
  • 00:34:07
    begin is it just to destroy an embryo
  • 00:34:09
    cell if it has the potential to cure
  • 00:34:11
    countless numbers of patients political
  • 00:34:14
    leaders are debating how to regulate and
  • 00:34:17
    fund research studies that involve the
  • 00:34:19
    techniques used to remove the embryo
  • 00:34:21
    cells no clear consensus has emerged
  • 00:34:25
    other recent discoveries May extinguish
  • 00:34:27
    the need need for embryonic stem
  • 00:34:30
    cells much of the criticism has been a
  • 00:34:32
    result of religious beliefs and in the
  • 00:34:34
    most high-profile case US President
  • 00:34:37
    George W Bush signed an executive order
  • 00:34:40
    Banning the use of federal funding for
  • 00:34:42
    any cell lines other than those already
  • 00:34:44
    in existence stating at the time my
  • 00:34:47
    position on these issues is shaped by
  • 00:34:49
    deeply held beliefs and I also believe
  • 00:34:53
    human life is a sacred gift from our
  • 00:34:56
    creator this B was in part revoked by
  • 00:34:59
    his successor Barack Obama who stated as
  • 00:35:02
    a person of faith I believe we are
  • 00:35:04
    called to care for each other and work
  • 00:35:06
    to ease human suffering I believe we
  • 00:35:09
    have been given the capacity and will to
  • 00:35:11
    pursue this research and the humanity
  • 00:35:13
    and conscience to do so
  • 00:35:16
    responsibly some stem cell researchers
  • 00:35:18
    are working to develop techniques of
  • 00:35:20
    isolating stem cells that are as potent
  • 00:35:22
    as embryonic stem cells but do not
  • 00:35:25
    require a human
  • 00:35:26
    embryo foremost among these was the
  • 00:35:29
    discovery in August 2006 that adult
  • 00:35:32
    cells can be reprogrammed in a plottin
  • 00:35:34
    state by the introduction of four
  • 00:35:36
    specific transcription factors resulting
  • 00:35:39
    in induced plottin stem cells this major
  • 00:35:42
    breakthrough won a Nobel prize for the
  • 00:35:45
    discoverers shinya yamanaka and John
  • 00:35:49
    giran in an alternative technique
  • 00:35:51
    researchers at Harvard University led by
  • 00:35:54
    Kevin Egan and citri marage have
  • 00:35:56
    transferred the new nucleus of a sematic
  • 00:35:58
    cell into an existing embryonic stem
  • 00:36:01
    cell thus creating a new stem cell
  • 00:36:04
    line researchers at Advanced cell
  • 00:36:06
    technology led by Robert Lanza and
  • 00:36:09
    Travis Wall reported the successful
  • 00:36:11
    derivation of a stem cell line using a
  • 00:36:13
    process similar to pre-implantation
  • 00:36:16
    genetic diagnosis in which a single
  • 00:36:18
    blastomere is extracted from a blast
  • 00:36:21
    assy at the 2007 meeting of the
  • 00:36:24
    international Society for stem cell
  • 00:36:26
    research the ISS CR Lanza announced that
  • 00:36:29
    his team had succeeded in producing
  • 00:36:31
    three new stem cell lines without
  • 00:36:33
    destroying the parent embryos these are
  • 00:36:36
    the first human embryonic cell lines in
  • 00:36:38
    existence that didn't result from the
  • 00:36:40
    destruction of an
  • 00:36:42
    embryo Lanza is currently in discussions
  • 00:36:44
    with the National Institutes of Health
  • 00:36:46
    to determine whether the new techniqu
  • 00:36:48
    sidesteps US restrictions on federal
  • 00:36:51
    funding for ES cell
  • 00:36:53
    research Antony tler of Wake Forest
  • 00:36:56
    University says the fluid surrounding
  • 00:36:58
    the fetus has been found to contain stem
  • 00:37:00
    cells that when used correctly can be
  • 00:37:03
    differentiated towards cell types such
  • 00:37:05
    as fat bone muscle blood vessel nerve
  • 00:37:08
    and liver cells the extraction of this
  • 00:37:11
    fluid is not thought to harm the fetus
  • 00:37:13
    in any way he hopes that these cells
  • 00:37:16
    will provide a valuable resource for
  • 00:37:18
    tissue repair and for engineered organs
  • 00:37:21
    as
  • 00:37:22
    well stem cell debates have motivated
  • 00:37:25
    and reinvigorated the pro-life movement
  • 00:37:27
    whose members are concerned with the
  • 00:37:29
    rights and status of the embryo as an
  • 00:37:31
    early AED human life they believe that
  • 00:37:34
    embryonic stem cell research profits
  • 00:37:36
    from and violates the sanctity of life
  • 00:37:39
    and is tantamount to murder the
  • 00:37:41
    fundamental assertion of those who
  • 00:37:43
    oppose embryonic stem cell research is
  • 00:37:45
    the belief that human life is inviolable
  • 00:37:48
    combined with the belief that human life
  • 00:37:50
    begins when a sperm cell fertilizes an
  • 00:37:52
    egg cell to form a single cell the view
  • 00:37:55
    of those in favor is that these embryos
  • 00:37:58
    would otherwise be discarded and if used
  • 00:38:00
    as stem cells they can survive as part
  • 00:38:02
    of a living human
  • 00:38:05
    being a portion of stem cell researchers
  • 00:38:07
    use embryos that were created but not
  • 00:38:10
    used in invitro fertility treatments to
  • 00:38:12
    derive new stem cell lines most of these
  • 00:38:15
    embryos are to be destroyed or stored
  • 00:38:18
    for long periods of time long past their
  • 00:38:20
    viable storage life in the United States
  • 00:38:23
    alone an estimated at least 400,000 such
  • 00:38:27
    em OS exist this has led to some
  • 00:38:29
    opponents of abortion such as Senator
  • 00:38:32
    Orin hatch to support human embryonic
  • 00:38:34
    stem cell
  • 00:38:36
    research medical researchers widely
  • 00:38:38
    report that stem cell research has the
  • 00:38:40
    potential to dramatically alter
  • 00:38:42
    approaches to understanding and treating
  • 00:38:44
    diseases and to alleviate suffering in
  • 00:38:48
    the future most medical researchers
  • 00:38:50
    anticipate being able to use
  • 00:38:51
    Technologies derived from stem cell
  • 00:38:53
    research to treat a variety of diseases
  • 00:38:56
    and impairments
  • 00:38:58
    spinal cord injuries and Parkinson's
  • 00:39:00
    disease are two examples that have been
  • 00:39:02
    championed by high-profile media
  • 00:39:04
    personalities for instance Christopher
  • 00:39:06
    reev and Michael J fox who have lived
  • 00:39:09
    with these conditions
  • 00:39:11
    respectively the anticipated medical
  • 00:39:13
    benefits of stem cell research add
  • 00:39:15
    urgency to the debates which has been
  • 00:39:17
    appealed to by proponents of embryonic
  • 00:39:19
    stem cell
  • 00:39:21
    research in August 2000 the US National
  • 00:39:25
    Institutes of Health's guidelines stated
  • 00:39:28
    research involving human pluripotent
  • 00:39:30
    stem cells promises new treatments and
  • 00:39:33
    possible cures for many debilitating
  • 00:39:35
    diseases and injuries including
  • 00:39:37
    Parkinson's disease diabetes heart
  • 00:39:40
    disease multiple sclerosis Burns and
  • 00:39:42
    spinal cord
  • 00:39:44
    injuries the NIH believes the potential
  • 00:39:47
    medical benefits of human plottin stem
  • 00:39:49
    cell technology are compelling and
  • 00:39:51
    worthy of pursuit in accordance with
  • 00:39:53
    appropriate ethical
  • 00:39:55
    standards in 2006 researchers at
  • 00:39:59
    Advanced cell technology of Worcester
  • 00:40:01
    Massachusetts succeeded in obtaining
  • 00:40:03
    stem cells from Mouse embryos without
  • 00:40:06
    destroying the embryos if this technique
  • 00:40:09
    and its reliability are improved it
  • 00:40:11
    would alleviate some of the ethical
  • 00:40:12
    concerns related to embryonic stem cell
  • 00:40:16
    research another technique announced in
  • 00:40:18
    2007 may also diffuse the long-standing
  • 00:40:21
    debate and
  • 00:40:22
    controversy research teams in the United
  • 00:40:25
    States and Japan have developed a simple
  • 00:40:27
    and cost-effective method of
  • 00:40:29
    reprogramming human skin cells to
  • 00:40:31
    function much like embryonic stem cells
  • 00:40:33
    by introducing artificial
  • 00:40:36
    viruses while extracting and cloning
  • 00:40:38
    stem cells is complex and extremely
  • 00:40:40
    expensive the newly discovered method of
  • 00:40:42
    reprogramming cells is much cheaper
  • 00:40:45
    however the technique may disrupt the
  • 00:40:47
    DNA in the new stem cells resulting in
  • 00:40:50
    damaged and cancerous tissue more
  • 00:40:53
    research will be required before
  • 00:40:55
    non-cancerous stem cells can be created
  • 00:41:06
    the planned treatment trials will focus
  • 00:41:08
    on the effects of oral lithium on
  • 00:41:10
    neurological function in people with
  • 00:41:12
    chronic spinal cord injury and those who
  • 00:41:14
    have received umbilical cord blood
  • 00:41:16
    mononuclear cell transplants to the
  • 00:41:18
    spinal cord the interest in these two
  • 00:41:21
    treatments derives from recent reports
  • 00:41:23
    indicating that umbilical cord blood
  • 00:41:25
    stem cells may be beneficial for spinal
  • 00:41:28
    cord injury and that lithium May promote
  • 00:41:30
    regeneration and recovery of function
  • 00:41:32
    after spinal cord injury both lithium
  • 00:41:35
    and umbilical cord blood are widely
  • 00:41:37
    available therapies that have long been
  • 00:41:39
    used to treat diseases in humans
  • 00:41:42
    embryonic stem cells have the potential
  • 00:41:44
    to grow indefinitely in a laboratory
  • 00:41:46
    environment and can differentiate into
  • 00:41:48
    almost all types of bodily tissue this
  • 00:41:51
    makes embryonic stem cells a prospect
  • 00:41:54
    for cellular therapies to treat a wide
  • 00:41:56
    range of diseases
  • 00:41:59
    prolife supporters often claim that the
  • 00:42:01
    use of adult stem cells from sources
  • 00:42:03
    such as the umbilical cord blood has
  • 00:42:05
    consistently produced more promising
  • 00:42:07
    results than the use of embryonic stem
  • 00:42:09
    cells furthermore adult stem cell
  • 00:42:12
    research may be able to make great
  • 00:42:14
    advances if less money and resources
  • 00:42:16
    were channeled into embryonic stem cell
  • 00:42:19
    research stem cell research is highly
  • 00:42:21
    frowned upon in many ethical and
  • 00:42:23
    religious
  • 00:42:24
    groups in the past it's been an
  • 00:42:27
    necessity to research embryonic stem
  • 00:42:29
    cells and in doing so destroy them for
  • 00:42:31
    research to progress as a result of the
  • 00:42:34
    research done with both embryonic and
  • 00:42:37
    adult stem cells new techniques may make
  • 00:42:39
    the necessity for embryonic cell
  • 00:42:41
    research
  • 00:42:43
    obsolete because many of the
  • 00:42:44
    restrictions placed on stem cell
  • 00:42:46
    research have been based on moral
  • 00:42:48
    dilemas surrounding the use of embryonic
  • 00:42:50
    cells there will likely be rapid
  • 00:42:52
    advancement in the field as the
  • 00:42:54
    techniques that created those issues are
  • 00:42:56
    becoming less of a
  • 00:42:58
    necessity many funding and research
  • 00:43:01
    restrictions on embryonic cell research
  • 00:43:03
    will not impact research on ipscs
  • 00:43:06
    allowing for a promising portion of the
  • 00:43:07
    field of research to continue relatively
  • 00:43:10
    unhindered by the ethical issues of
  • 00:43:12
    embryonic
  • 00:43:14
    research adult stem cells have provided
  • 00:43:16
    many different therapies for illnesses
  • 00:43:18
    such as Parkinson's disease leukemia
  • 00:43:21
    multiple sclerosis lupus sickle cell
  • 00:43:24
    anemia and heart damage to date
  • 00:43:27
    embryonic stem cells have also been used
  • 00:43:29
    in treatment moreover there have been
  • 00:43:32
    many advances in adult stem cell
  • 00:43:34
    research including a recent study where
  • 00:43:36
    ppant adult stem cells were manufactured
  • 00:43:39
    from differentiated fibroblast by the
  • 00:43:41
    addition of specific transcription
  • 00:43:44
    factors newly created stem cells were
  • 00:43:47
    developed into an embryo and were
  • 00:43:48
    integrated into newborn Mouse tissues
  • 00:43:51
    analogous to the properties of embryonic
  • 00:43:53
    stem
  • 00:43:54
    cells research is underway to develop
  • 00:43:57
    various sources for stem cells and to
  • 00:43:59
    apply stem cell treatments for
  • 00:44:01
    neurodegenerative diseases and
  • 00:44:03
    conditions diabetes heart disease and
  • 00:44:06
    other conditions research is also
  • 00:44:08
    underway in generating organoids using
  • 00:44:11
    stem cells which would allow for further
  • 00:44:13
    understanding of human development
  • 00:44:15
    organogenesis and modeling of human
  • 00:44:19
    diseases in more recent years with the
  • 00:44:21
    ability of scientists to isolate and
  • 00:44:23
    culture embryonic stem cells and with
  • 00:44:26
    Scientists growing ability to create
  • 00:44:28
    stem cells using somatic cell nuclear
  • 00:44:30
    transfer and techniques to create
  • 00:44:32
    induced plottin stem cells controversy
  • 00:44:35
    has crept in both related to abortion
  • 00:44:38
    politics and to human
  • 00:44:40
    cloning hepatoxicity and drug induced
  • 00:44:43
    liver injury account for a substantial
  • 00:44:45
    number of failures of new drugs in
  • 00:44:47
    development and Market withdrawal
  • 00:44:49
    highlighting the need for screening
  • 00:44:51
    assays such as stem cell derived hepy
  • 00:44:54
    like cells that are capable of detecting
  • 00:44:56
    toxicity early in the drug development
  • 00:44:59
    process so where will this research take
  • 00:45:02
    us it may be at times an alarming
  • 00:45:05
    Prospect but even the toughest of
  • 00:45:07
    well-traveled Roads started with the
  • 00:45:09
    first few frightening steps steps that
  • 00:45:12
    were necessary in order to get to a
  • 00:45:14
    wonderful and at times better place that
  • 00:45:18
    is the true magic of science
  • 00:45:21
    [Music]
Tags
  • Stem Cells
  • Regenerative Medicine
  • Embryonic Stem Cells
  • Adult Stem Cells
  • iPSCs
  • Ethics
  • DNA Repair
  • Medical Research
  • Cell Differentiation
  • Tissue Regeneration